You can:
Name | D(1B) dopamine receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | DRD5 |
Synonym | Gpcr1 DRD1L2 DRD1B dopamine receptor 5 Dopamine D5 receptor [ Show all ] |
Disease | Solid tumours Schizophrenia |
Length | 477 |
Amino acid sequence | MLPPGSNGTAYPGQFALYQQLAQGNAVGGSAGAPPLGPSQVVTACLLTLLIIWTLLGNVLVCAAIVRSRHLRANMTNVFIVSLAVSDLFVALLVMPWKAVAEVAGYWPFGAFCDVWVAFDIMCSTASILNLCVISVDRYWAISRPFRYKRKMTQRMALVMVGLAWTLSILISFIPVQLNWHRDQAASWGGLDLPNNLANWTPWEEDFWEPDVNAENCDSSLNRTYAISSSLISFYIPVAIMIVTYTRIYRIAQVQIRRISSLERAAEHAQSCRSSAACAPDTSLRASIKKETKVLKTLSVIMGVFVCCWLPFFILNCMVPFCSGHPEGPPAGFPCVSETTFDVFVWFGWANSSLNPVIYAFNADFQKVFAQLLGCSHFCSRTPVETVNISNELISYNQDIVFHKEIAAAYIHMMPNAVTPGNREVDNDEEEGPFDRMFQIYQTSPDGDPVAESVWELDCEGEISLDKITPFTPNGFH |
UniProt | P21918 |
Protein Data Bank | N/A |
GPCR-HGmod model | P21918 |
3D structure model | This predicted structure model is from GPCR-EXP P21918. |
BioLiP | N/A |
Therapeutic Target Database | T46828 |
ChEMBL | CHEMBL1850 |
IUPHAR | 218 |
DrugBank | BE0000145, BE0004889 |
Name | SMR000047376 |
---|---|
Molecular formula | C19H21ClN8 |
IUPAC name | 2-N-(4-chlorophenyl)-6-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-1,3,5-triazine-2,4-diamine |
Molecular weight | 396.883 |
Hydrogen bond acceptor | 8 |
Hydrogen bond donor | 2 |
XlogP | 2.9 |
Synonyms | 827002-46-0 HMS2360A24 N2-(4-chlorophenyl)-6-[[4-(2-pyridinyl)-1-piperazinyl]methyl]-1,3,5-triazine-2,4-diamine AKOS005512111 MLS002584691 [ Show all ] |
Inchi Key | JBQYOMAORVUETK-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C19H21ClN8/c20-14-4-6-15(7-5-14)23-19-25-16(24-18(21)26-19)13-27-9-11-28(12-10-27)17-3-1-2-8-22-17/h1-8H,9-13H2,(H3,21,23,24,25,26) |
PubChem CID | 666078 |
ChEMBL | CHEMBL1600031 |
IUPHAR | N/A |
BindingDB | 48928 |
DrugBank | N/A |
Structure | ![]() |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 0.016 nM | N/A | BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417